Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Ex VP & Chief Commerc. Officer

Chief Financial Officer

GC & Chief Compliance Officer

President and CEO

See Remarks

Chief Business Officer

Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targets type III interferon receptors that has completed Phase II clinical trials; Lonafarnib for the treatment of progeria and progeroid laminopathies; and Avexitide for the treatment of congenital hyperinsulinism, as well as has completed Phase II clinical trials to treat post-bariatric hypoglycemia. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is headquartered in Palo Alto, California.

Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-11-02	Premium	bought	Premium	Premium	Premium	-
2023-11-01	Premium	bought	Premium	Premium	Premium	-
2023-10-31	Premium	bought	Premium	Premium	Premium	-
2023-10-31	Premium	bought	Premium	Premium	Premium	-
2023-03-17	Premium	sold	Premium	Premium	Premium	Ex VP & Chief Commerc. Officer
2023-01-23	Premium	bought	Premium	Premium	Premium	-
2022-12-29	Premium	sold	Premium	Premium	Premium	-
2022-12-22	Premium	sold	Premium	Premium	Premium	-
2022-12-22	Premium	bought	Premium	Premium	Premium	-
2022-08-16	Premium	sold	Premium	Premium	Premium	-
2022-03-14	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2022-03-14	Premium	sold	Premium	Premium	Premium	Ex VP & Chief Commerc. Officer
2022-03-11	Premium	acquired	Premium	Premium	Premium	GC & Chief Compliance Officer
2022-03-11	Premium	acquired	Premium	Premium	Premium	-
2022-03-11	Premium	acquired	Premium	Premium	Premium	-
2022-03-11	Premium	acquired	Premium	Premium	Premium	-
2022-03-11	Premium	acquired	Premium	Premium	Premium	-
2022-03-11	Premium	acquired	Premium	Premium	Premium	-
2022-03-11	Premium	acquired	Premium	Premium	Premium	President and CEO
2022-03-11	Premium	acquired	Premium	Premium	Premium	-
2022-03-11	Premium	acquired	Premium	Premium	Premium	Ex VP & Chief Commerc. Officer
2022-03-11	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-03-11	Premium	acquired	Premium	Premium	Premium	-
2022-01-07	Premium	sold	Premium	Premium	Premium	Ex VP & Chief Commerc. Officer
2021-04-09	Premium	bought	Premium	Premium	Premium	-

EIGR - Eiger BioPharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for EIGR